New combo drug for obesity tested in japanese volunteers
NCT ID NCT06297616
First seen Jan 20, 2026 · Last updated May 30, 2026 · Updated 19 times
Summary
This study tested the safety of a new drug called LY3841136, given alone or with another drug (tirzepatide), in 128 Japanese adults who are obese or overweight. Researchers monitored side effects and how the body processes the drugs over several months. The goal was to see if the combination is safe and tolerable for weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
P-One Clinic
Hachiōji, Tokyo, 192-0071, Japan
-
Sumida Hospital
Sumida-ku, Tokyo, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.